Literature DB >> 11698576

Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.

H Torrenga, J Licht, J J van der Hoeven, O S Hoekstra, S Meijer, P J van Diest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11698576     DOI： 10.1093/jnci/93.21.1659

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.

Authors:  Jacobus J M van der Hoeven; Otto S Hoekstra; Emile F I Comans; Rik Pijpers; Robert P A Boom; Dick van Geldere; Sybren Meijer; Adriaan A Lammertsma; Gerrit J J Teule
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.

Authors:  G S Mijnhout; O S Hoekstra; A van Lingen; P J van Diest; H J Adèr; A A Lammertsma; R Pijpers; S Meijer; G J J Teule
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

3.  Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

Authors:  Jolijn Brouwer; Remco de Bree; Emile F I Comans; Jonas A Castelijns; Otto S Hoekstra; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.